Bioequivalence standards for generic drugs have long ignored batch-to-batch variability, risking false conclusions. New guidelines now require multi-batch testing to ensure real-world equivalence and patient safety.
Jan, 3 2026
Oct, 3 2024
Sep, 30 2025
Dec, 5 2025
Dec, 6 2025